{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:00:57Z","timestamp":1774972857923,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lpm.2021.104076","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T21:03:48Z","timestamp":1634850228000},"page":"104076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hypophysitis: A comprehensive overview"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-6093","authenticated-orcid":false,"given":"F.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.R","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-9866","authenticated-orcid":false,"given":"A.M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0001","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/EJE-19-1051","article-title":"Mechanisms in endocrinology: autoimmune hypopituitarism: novel mechanistic insights","volume":"182","author":"Takahashi","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104076_bib0002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune Hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0003","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1530\/EJE-17-0009","article-title":"Mechanisms In Endocrinology: hypophysitis: diagnosis and treatment","volume":"179","author":"Joshi","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0044-101036","article-title":"Clinical, endocrine and imaging characteristics of patients with primary hypophysitis","volume":"50","author":"Angelousi","year":"2018","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.lpm.2021.104076_bib0005","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0006","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11547-019-01120-x","article-title":"Imaging findings in hypophysitis: a review","volume":"125","author":"Caranci","year":"2020","journal-title":"Radiol Med"},{"issue":"9","key":"10.1016\/j.lpm.2021.104076_bib0007","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3174\/ajnr.A1714","article-title":"A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively","volume":"30","author":"Gutenberg","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0008","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11102-018-0892-4","article-title":"Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis","volume":"21","author":"Tartaglione","year":"2018","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11102-016-0736-z","article-title":"Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects","volume":"19","author":"Bellastella","year":"2016","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0011","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11102-013-0498-9","article-title":"Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy","volume":"17","author":"Caputo","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.lpm.2021.104076_bib0012","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1100\/tsw.2010.24","article-title":"Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities\u2013report of a case and literature review","volume":"10","author":"Curt\u00f2","year":"2010","journal-title":"Sci World J"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11102-019-01005-2","article-title":"Granulomatous hypophysitis causing compression of the internal carotid arteries reversible with azathioprine and rituximab treatment","volume":"23","author":"Gendreitzig","year":"2020","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.lpm.2021.104076_bib0014","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1136\/jnnp.74.11.1581","article-title":"Lymphocytic hypophysitis successfully treated with azathioprine: first case report","volume":"74","author":"Lecube","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.lpm.2021.104076_bib0015","first-page":"e245","article-title":"Diagnosis and treatment of autoimmune hypophysitis: a short review","volume":"34","author":"Lupi","year":"2011","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11102-010-0252-5","article-title":"Azathioprine as an alternative treatment in primary hypophysitis","volume":"14","author":"Papanastasiou","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.lpm.2021.104076_bib0017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fendo.2020.00350","article-title":"A remarkable response of granulomatous hypophysitis to infliximab in a patient with a background of Crohn's disease-a case report","volume":"11","author":"Force","year":"2020","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0018","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11102-014-0592-7","article-title":"Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab","volume":"18","author":"Xu","year":"2015","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0019","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jemermed.2018.07.005","article-title":"Management of immune checkpoint inhibitor toxicities: a review and clinical guideline for emergency physicians","volume":"55","author":"Hryniewicki","year":"2018","journal-title":"J Emerg Med"},{"issue":"7","key":"10.1016\/j.lpm.2021.104076_bib0020","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0021","doi-asserted-by":"crossref","first-page":"bvaa048","DOI":"10.1210\/jendso\/bvaa048","article-title":"A case series of patients with isolated IgG4-related hypophysitis treated with rituximab","volume":"4","author":"Boharoon","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.lpm.2021.104076_bib0022","article-title":"Rituximab treatment for isolated IgG4-related hypophysitis in a teenage female","volume":"2018","author":"Bullock","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/17446651.2014.913979","article-title":"Rituximab-induced remission of autoimmune hypophysitis and primary immune thrombocytopenia in a patient with autoimmune polyendocrine syndrome type 4","volume":"9","author":"De Bellis","year":"2014","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.lpm.2021.104076_bib0024","doi-asserted-by":"crossref","first-page":"e6934","DOI":"10.1097\/MD.0000000000006934","article-title":"Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: a case report and literature review","volume":"96","author":"Gu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2021.104076_bib0025","article-title":"Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil","volume":"2020","author":"Lin","year":"2020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0026","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4997\/jrcpe.2020.315","article-title":"Hypophysitis in granulomatosis with polyangiitis: rare presentation of a multisystem disease","volume":"50","author":"Ramakrishna","year":"2020","journal-title":"J R Coll Physicians Edinb"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0027","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3171\/2012.2.JNS111456","article-title":"Novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab","volume":"116","author":"Schreckinger","year":"2012","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.lpm.2021.104076_bib0028","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1097\/RLU.0000000000002514","article-title":"Therapeutic response to rituximab in IgG4-related hypophysitis evidenced on 18F-FDG PET and MRI","volume":"44","author":"Vauchot","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.lpm.2021.104076_bib0029","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.autrev.2008.04.016","article-title":"Pituitary autoimmunity: 30 years later","volume":"7","author":"Caturegli","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.lpm.2021.104076_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-018-0904-4","article-title":"The experience with transsphenoidal surgery and its importance to outcomes","volume":"21","author":"Honegger","year":"2018","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.lpm.2021.104076_bib0031","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.2018-01021","article-title":"Hypophysitis outcome and factors predicting responsiveness to glucocorticoid therapy: a prospective and double-arm study","volume":"103","author":"Chiloiro","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.lpm.2021.104076_bib0032","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1210\/jc.2015-2146","article-title":"Treatment of primary hypophysitis in Germany","volume":"100","author":"Honegger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0033","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/a-1163-7304","article-title":"Clinical characteristics of primary hypophysitis - a single-centre series of 60 cases","volume":"129","author":"Amereller","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EJE-17-0123","article-title":"Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis","volume":"177","author":"Lupi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/eje.1.02183","article-title":"Primary hypophysitis: clinical-pathological correlations","volume":"155","author":"Gutenberg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2021.104076_bib0036","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fendo.2017.00166","article-title":"Autoimmune abnormalities of postpartum thyroid diseases","volume":"8","author":"Di Bari","year":"2017","journal-title":"Front Endocrinol"},{"issue":"9-10","key":"10.1016\/j.lpm.2021.104076_bib0037","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1159\/000506903","article-title":"Hypophysitis (including IgG4 and immunotherapy)","volume":"110","author":"Angelousi","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.lpm.2021.104076_bib0038","series-title":"Endotext. South Dartmouth (MA)","article-title":"Hypophysitis","author":"Prete","year":"2000"},{"issue":"11","key":"10.1016\/j.lpm.2021.104076_bib0039","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1507\/endocrj.EJ20-0436","article-title":"Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands","volume":"67","author":"Iwama","year":"2020","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/path.5046","article-title":"Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis","volume":"244","author":"Yasuda","year":"2018","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0041","doi-asserted-by":"crossref","first-page":"43492","DOI":"10.1038\/srep43492","article-title":"In Situ activation of pituitary-infiltrating T lymphocytes in autoimmune hypophysitis","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.lpm.2021.104076_bib0042","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1210\/jc.2015-2702","article-title":"HLA markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis","volume":"100","author":"Heaney","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0043","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI44073","article-title":"Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans","volume":"121","author":"Yamamoto","year":"2011","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0044","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz003","article-title":"Autoimmune pituitary disease: new concepts with clinical implications","volume":"41","author":"Yamamoto","year":"2020","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.lpm.2021.104076_bib0045","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1210\/js.2019-00243","article-title":"Pathogenesis of anti-PIT-1 antibody syndrome: PIT-1 presentation by HLA class I on anterior pituitary cells","volume":"3","author":"Kanie","year":"2019","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0046","doi-asserted-by":"crossref","first-page":"bvaa194","DOI":"10.1210\/jendso\/bvaa194","article-title":"Two cases of anti-PIT-1 hypophysitis exhibited as a form of paraneoplastic syndrome not associated with thymoma","volume":"5","author":"Kanie","year":"2021","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0047","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11102-016-0773-7","article-title":"Critical review of IgG4-related hypophysitis","volume":"20","author":"Shikuma","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.lpm.2021.104076_bib0048","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5382640","article-title":"Clinical characteristics of 76 patients with IgG4-Related hypophysitis: a systematic literature review","volume":"2019","author":"Li","year":"2019","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0049","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1507\/endocrj.EJ13-0407","article-title":"Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis","volume":"61","author":"Iseda","year":"2014","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s12020-014-0497-2","article-title":"Langerhans cell histiocytosis and pituitary function","volume":"48","author":"Makras","year":"2015","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0051","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2020.104016","article-title":"IgG4 hypophysitis: diagnosis and management","volume":"49","author":"Lojou","year":"2020","journal-title":"Presse Med"},{"issue":"7","key":"10.1016\/j.lpm.2021.104076_bib0053","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2010-2970","article-title":"IgG4-related hypophysitis: a new addition to the hypophysitis spectrum","volume":"96","author":"Leporati","year":"2011","journal-title":"J Clin Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0054","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bpa.12459","article-title":"IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis","volume":"27","author":"Bernreuther","year":"2017","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11102-013-0510-4","article-title":"Idiopathic granulomatous hypophysitis: a systematic review of 82 cases in the literature","volume":"17","author":"Hunn","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.lpm.2021.104076_bib0056","article-title":"Postpartum granulomatous hypophysitis: a case study, review of the literature, and discussion of pathogenesis","volume":"2016","author":"Joneja","year":"2016","journal-title":"Case Rep Pathol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0057","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00000478-199806000-00011","article-title":"Xanthomatous hypophysitis","volume":"22","author":"Folkerth","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2021.104076_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/195323","article-title":"Xanthomatous hypophysitis mimicking a pituitary adenoma: case report and review of the literature","volume":"2010","author":"Aste","year":"2010","journal-title":"J Oncol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0059","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bpa.12498","article-title":"Review of xanthomatous lesions of the sella","volume":"27","author":"Kleinschmidt-DeMasters","year":"2017","journal-title":"Brain Pathol"},{"issue":"7","key":"10.1016\/j.lpm.2021.104076_bib0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jocn.2015.01.019","article-title":"Xanthomatous hypophysitis","volume":"22","author":"Hanna","year":"2015","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0061","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/B:PITU.0000011177.43408.56","article-title":"Xanthomatous pituitary lesions: a report of two cases and review of the literature","volume":"6","author":"Burt","year":"2003","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0062","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.pas.0000149707.12335.8e","article-title":"Immunopathology of primary hypophysitis: implications for pathogenesis","volume":"29","author":"Gutenberg","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0063","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/EP:13:3:183","article-title":"Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases","volume":"13","author":"Tashiro","year":"2002","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104076_bib0064","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s004010051001","article-title":"Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma","volume":"97","author":"Paulus","year":"1999","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11102-011-0307-2","article-title":"Necrotizing infundibulo-hypophysitis: an entity too rare to be true?","volume":"15","author":"Gutenberg","year":"2012","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.lpm.2021.104076_bib0066","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2021.104076_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathol-020712-163959","article-title":"Pathogenesis of langerhans cell histiocytosis","volume":"8","author":"Badalian-Very","year":"2013","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"10.1016\/j.lpm.2021.104076_bib0068","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1111\/cas.13817","article-title":"Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment","volume":"109","author":"Kobayashi","year":"2018","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0069","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tem.2007.06.003","article-title":"Endocrine manifestations in Langerhans cell histiocytosis","volume":"18","author":"Makras","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00234-005-0011-x","article-title":"Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH)","volume":"48","author":"Makras","year":"2006","journal-title":"Neuroradiology"},{"key":"10.1016\/j.lpm.2021.104076_bib0071","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-8-72","article-title":"Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net","volume":"8","author":"Girschikofsky","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"25","key":"10.1016\/j.lpm.2021.104076_bib0072","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"H\u00e9ritier","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0073","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2016-12-757823","article-title":"Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults","volume":"130","author":"Milne","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0074","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/jc.2015-3357","article-title":"Endocrine manifestations in a monocentric cohort of 64 patients with Erdheim-Chester disease","volume":"101","author":"Courtillot","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104076_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.04.010","article-title":"New causes of hypophysitis","volume":"33","author":"Yuen","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0076","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1530\/EJE-19-0169","article-title":"Management of endocrine disease: immune check point inhibitors-induced hypophysitis","volume":"181","author":"Albarel","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"230","key":"10.1016\/j.lpm.2021.104076_bib0077","doi-asserted-by":"crossref","first-page":"230ra45","DOI":"10.1126\/scitranslmed.3008002","article-title":"Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody","volume":"6","author":"Iwama","year":"2014","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.lpm.2021.104076_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152009","article-title":"The role of macrophages type 2 and T-regs in immune checkpoint inhibitor related adverse events","volume":"225","author":"Mihic-Probst","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.lpm.2021.104076_bib0079","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejca.2020.02.049","article-title":"Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor-induced secondary adrenal insufficiency","volume":"130","author":"Yano","year":"2020","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.lpm.2021.104076_bib0080","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1002\/cam4.2661","article-title":"Immune checkpoint inhibitor-associated pituitary-adrenal dysfunction: a systematic review and meta-analysis","volume":"8","author":"Lu","year":"2019","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0081","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/17446651.2019.1701434","article-title":"Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment","volume":"14","author":"Di Dalmazi","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.lpm.2021.104076_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102590","article-title":"Immune checkpoint inhibitors-induced autoimmunity: the impact of gender","volume":"19","author":"Triggianese","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0083","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EJE-19-0238","article-title":"Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis","volume":"181","author":"Faje","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.lpm.2021.104076_bib0084","first-page":"6175","volume":"28","author":"Cooksley","year":"2020","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.lpm.2021.104076_bib0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11102-018-0866-6","article-title":"Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis","volume":"21","author":"De Sousa","year":"2018","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.lpm.2021.104076_bib0086","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40618-020-01297-3","article-title":"Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSH","volume":"44","author":"Siddiqui","year":"2021","journal-title":"J Endocrinol Investig"},{"issue":"10","key":"10.1016\/j.lpm.2021.104076_bib0087","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103280","article-title":"Anti-PD1 and anti-PDL1-induced hypophysitis: a cohort study of 17 patients with longitudinal follow-up","volume":"9","author":"Levy","year":"2020","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.lpm.2021.104076_bib0088","first-page":"1683","article-title":"MRI findings of immune checkpoint inhibitor-induced hypophysitis: possible association with fibrosis","volume":"41","author":"Kurokawa","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104076_bib0089","first-page":"e5001","article-title":"A rare case of ipilimumab-induced reversible hypophysitis and permanent primary hypothyroidism","volume":"11","author":"Erra","year":"2019","journal-title":"Cureus"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:08:57Z","timestamp":1760105337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0755498221000154"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104076","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypophysitis: A comprehensive overview","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104076"}}